Strength
325 mg/1
Manufacturer
McKessonNDC
68599467909
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACETAMINOPHENApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
4/1/2021
Price Statistics
The NADAC for ACETAMINOPHEN 325 MG TABLET has been published 209 times since Aug 24, 2022, and over the history we have for it it has risen 8.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0238 per EA |
|---|---|
| All-time high | $0.0267 (Nov 13, 2024) |
| All-time low | $0.0219 (Aug 23, 2023) |
| 52-week high | $0.0267 |
| 52-week low | $0.0238 |
| Median price | $0.0245 |
| Average price | $0.0245 |
| Largest weekly change | -17.3% (Nov 20, 2024) |
| Weeks tracked | 209 |
| Tracking since | Aug 24, 2022 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ACETAMINOPHEN 325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ACETAMINOPHEN 325 MG TABLET, manufactured by McKesson, is $0.0238 per EA (NDC 68599467909), effective Aug 19, 2026.
How has the price of ACETAMINOPHEN 325 MG TABLET changed over time?
Over the history we have for it, the NADAC for ACETAMINOPHEN 325 MG TABLET has risen 8.1%. It has been tracked across 209 weekly CMS publications since Aug 24, 2022.
What are the highest and lowest recorded NADAC prices for ACETAMINOPHEN 325 MG TABLET?
Since Aug 24, 2022, the NADAC for ACETAMINOPHEN 325 MG TABLET has ranged from a low of $0.0219 (Aug 23, 2023) to a high of $0.0267 (Nov 13, 2024), with a median of $0.0245 per EA.
Are there cheaper alternatives to ACETAMINOPHEN 325 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QC PAIN RELIEF 325 MG TABLET, is $0.0232 per EA — about 2% below ACETAMINOPHEN 325 MG TABLET.
Who manufactures ACETAMINOPHEN 325 MG TABLET?
ACETAMINOPHEN 325 MG TABLET (NDC 68599467909) is labeled by McKesson, and CMS classifies it as a generic product.